Skip to main content

Table 1 The number and age-standardized rate of eye skin cancers by age groups, genders, morphology types, and human development index levels at provincial level in Iran in 2005 and 2016

From: A registration trend in eyelid skin cancers and associated risk factors in Iran, 2005–2016

Characteristics

2005

2016

2005–2016

N

Crude rate, per 100,000 pop

ASIR per 100,000 pop

N

Crude rate, per 100,000 pop

ASIR per 100,000 pop

Change in number (%)

EAPC in ASIR (95%CI)

Overall

474

0.665

27.23

846

1.058

36.56

78.48

1.511(0.00–2.942)

Age(year)

 < 50 year

67

0.109

3.14

136

0.208

4.17

102.98

0.200(-2.955–3.355)

 ≥ 50 year

407

4.168

24.09

710

5.005

32.39

74.45

1.715(0.200–3.149)

Gender

 Male

258

0.712

1.162

485

1.197

1.504

87.9

2.020(-3.825–8.329)

 Female

216

0.617

1.091

361

0.916

1.297

67.13

1.410(-4.496–7.573)

Morphology

 Carcinomas

451

0.633

26.078

727

0.909

32.347

61.19

0.904(-0.698 – 2.429)

 BCC

541

0.767

17.32

700

0.876

27.18

29.39

3.355(1.005–5.759)

 Adenocarcinomas

15

0.021

0.831

11

0.014

0.262

-26.68

-0.399(-5.257–4.812)

 Melanomas

3

0.004

0.077

25

0.031

1.078

733.33

10.517(4.185–17.351)

 Others skin tumors

5

0.007

0.249

83

0.104

2.871

1560

7.681(-22.818–50.080)

HDI levels

 Low

83

0.683

10.045

100

0.729

9.399

20.48

0.501(-1.193 -2.224)

 Medium

146

0.641

8.723

284

1.119

13.793

94.52

2.737(-0.598–6.290)

 High

245

0.675

8.466

462

1.131

13.365

88.57

3.977(0.401–7.681)

  1. N Number, ASR Age-standardized rate, EAPC The estimated annual percentage change, CI Confidence interval, HDI Human development index, BCC Basal cell carcinoma. Percentage change in absolute number was calculated based on the row data. HDI: low, HDI < 0.68; medium, 0.68 ≤ HDI < 0.70; high, HDI ≥ 0.70